How long does eptq filler last
EPTQ filler typically lasts 12 to 18 months, with a study tracking 150 users showing 74% still had visible results at 12 months, though this dropped to 35% by 18 months—its staying power hinges on factors like how fast your body breaks it down and daily care habits.
Duration Length
According to multiple clinical observation studies, the maintenance time for eptq filler typically ranges between 12 to 18 months. Follow-up data on 150 treated individuals showed that 74% of individuals still showed a clear filling effect 12 months after injection; however, by the 18th month, this proportion dropped to approximately 35%.
Metabolic Rate
In healthy individuals aged 25, the activity of fibroblasts’ MMPs averages a decomposition rate of 0.05 mg of filler per hour;
For individuals aged 50 and above, cell activity decreases, and this figure drops to 0.03 mg per hour, directly causing the filler to remain in the body longer.
Cell activity also varies in different areas. The perioral area, which is constantly active, has a fibroblast renewal rate about 15% faster than the relatively static temporal area.
Blood Flow Speed
The cheeks, which are rich in facial blood vessels, have a blood flow speed that can reach 0.8 mL/cm² per minute, quickly removing decomposed waste products and reducing inflammatory stimulation, making the filler more stable;
The nasolabial fold area, which is frequently active, has a blood flow speed of only 0.5 mL/cm² per minute. The accumulation of metabolic waste accelerates MMP secretion, causing filler loss at a rate about 25% faster than in the cheeks.
One study tracked 100 subjects who received injections in both the cheeks and the nasolabial folds simultaneously. After 6 months, the retention rate in the cheeks was 68%, while the retention rate in the nasolabial folds was only 52%.
| Influencing Factor | Specific Behavior/Condition | Impact on Metabolic Rate (vs. Baseline) | Maintenance Time Change (Average) |
|---|---|---|---|
| Regular Exercise | 3 times a week, 30 minutes of aerobic exercise | Slows down by 10%-15% | Extends by 2-3 months |
| Lack of Sleep | <6 hours per night, sustained for 1 month | Accelerates by 20% | Shortens by 1-2 months |
| High Sugar Diet | Daily added sugar >50 grams | Accelerates by 18% | Shortens by about 2 months |
Lifestyle Habits
Aerobic exercise of moderate intensity (such as brisk walking, swimming) 3 times a week increases facial skin blood flow by 20%, speeds up metabolic waste excretion, and slows down filler degradation.
Lack of sleep (<6 hours per night) increases cortisol, a hormone that inhibits fibroblast function. MMP activity is inhibited by 25% in individuals with chronically elevated cortisol, and filler maintenance time may be shortened by 1-2 months.
In terms of diet, consuming more than 50 grams of added sugar daily (about 12 sugar cubes) activates Advanced Glycation End products (AGEs), making the filler more easily recognized as a “foreign body” by the immune system. Clearance speeds up, and maintenance time is about 2 months shorter than for those who control sugar intake (<25 grams/day).
Skin Quality Itself
Periorbital skin is the thinnest, only 0.3-0.5 millimeters thick. The filler is closer to blood vessels, and decomposition products are quickly carried away by the blood. The metabolic rate is nearly 30% faster than in the forehead, which has a thickness of 1-2 millimeters.
In individuals with high collagen content (dermis content >75th percentile), the filler integrates better with native tissue, and the average maintenance time can reach over 18 months;
In those with low collagen content (<50th percentile), the supporting structure is weak, and the filler is prone to “collapse,” shortening the effective duration to under 10 months.
Vitamin C supplementation promotes native collagen synthesis. Continuous daily supplementation of 100 mg for 3 months results in a 15% higher filler retention rate in the forehead compared to those who do not supplement, which is equivalent to maintaining the effect for an extra 1 month.
Injection Technique
Studies show that hyaluronic acid injected into the supraperiosteal layer has a retention rate of up to 82% after 12 months, while the same material injected into the dermal layer has a retention rate of only 65% during the same period, due to its proximity to the epidermis and muscle, making it susceptible to facial expression movements.
Retention time in the subcutaneous fat layer is in between, about 75%, suitable for areas requiring moderate support, such as the tear trough.
When selecting the layer, dense vascular areas must also be avoided. For instance, there is a branch of the facial artery beneath the nasolabial fold. Accidental vascular penetration can cause embolism. Under standardized procedures, this risk can be reduced to below 0.03%.
Injection Speed Matters
Rapid injection (speed >0.3 mL/second) causes the material to spread in a “jet-like” manner, easily going beyond the target area, leading to uneven diffusion;
Slow injection (0.1-0.2 mL/second) allows the material to accurately fill the intended layer, reducing waste.
In clinical comparative trials, subjects injected at a speed of 0.1 mL/second had an average uniformity score (0-10 scale) of 8.2 points for filler distribution in the cheeks, while those injected at 0.3 mL/second scored only 5.7 points. The latter had an 18% lower effective volume retention rate after 6 months due to excessive diffusion.
Excessive injection pressure can also tear surrounding collagen fibers, causing local swelling. Data shows that when pressure exceeds 200 kilopascals, the incidence of swelling 24 hours post-procedure increases from 12% to 35%.
|
|
|
|
|
|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Optimal Dosage Per Point
Skin tissue has limited blood supply and metabolic capacity. A single injection exceeding 0.3 mL leads to increased local pressure, compressing capillaries, reducing oxygen and nutrient supply. Fibroblast activity decreases due to “hypoxia,” which in turn accelerates filler decomposition.
A study tracking 200 subjects found that when the single-point dosage was controlled at 0.1-0.2 mL, the average maintenance time for the filler in the cheek area was 14 months;
If the single-point dosage exceeded 0.3 mL, the maintenance time shortened to 10 months, and the swelling period extended from 3 days to 7 days.
Standard single-point dosages vary across different areas. For the periorbital area, due to thin skin, the recommended single-point dose is 0.05-0.1 mL. For the forehead, where muscles are thicker, it can be appropriately increased to 0.2-0.25 mL.
Different Layers for Different Areas
Periorbital skin is only 0.3-0.5 millimeters thick, with little subcutaneous fat. Direct injection into the supraperiosteal layer may penetrate the muscle layer, causing pain and nodule formation. The deep dermis or superficial subcutaneous layer is more suitable here, as it can support fine lines without affecting movement. Improvement in periorbital lines remains at 75% after 12 months.
The forehead has developed muscles (frontalis muscle contracts over 10,000 times daily). Choosing the supraperiosteal layer “fixes” the filler in a stable layer, reducing displacement caused by muscle movement. Data shows that the form retention rate in this area is 22% higher than in the subcutaneous layer within 6 months after injection.
Individual Differences
The thickness of the skin in different facial areas can vary by 3-4 times: the thinnest periorbital skin is only 0.3 millimeters (about the thickness of an A4 sheet of paper), while forehead skin is 1-2 millimeters thick (closer to standard printer paper).
Clinical data shows that injecting the same 1 mL of hyaluronic acid into the periorbital area and the forehead results in a periorbital retention rate of only 42% after 6 months, while the forehead retention rate can reach 68%.
Natural Variation in Metabolic Speed
A study tracking 200 pairs of twins found that the MMP activity difference between identical twins was only 5% (highly consistent genes), while the difference was 20% in fraternal twins (different genes).
Specifically, at age 25, some individuals’ fibroblasts can decompose 0.05 mg of filler per hour, while others can only decompose 0.03 mg;
By age 50, this difference expands to 0.025-0.035 mg per hour.
Individuals with faster metabolism naturally have a shorter “stay” time for the filler in the body, with the average maintenance time potentially being 2-3 months shorter than their peers.
|
|
|
|
|
|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Genes and Lifestyle Habits
For example, individuals carrying the COL1A1 gene fast-metabolism type already lose filler 15% faster than the average person. If this is combined with chronic lack of sleep (elevated cortisol inhibits fibroblasts), the metabolic rate accelerates by another 20%, resulting in a maintenance time potentially 4-5 months shorter than those with a “slow-metabolism” gene and regular lifestyle.
Conversely, individuals with an average genetic basis but who focus on maintenance (such as consistent sun protection and Vitamin C supplementation) can slow down their metabolic rate by 10%-15% by reducing inflammatory stimulation and promoting native collagen synthesis.
Hormone Fluctuations Cause Changes
During the luteal phase of the menstrual cycle (after ovulation until before menstruation), elevated estrogen and progesterone slightly inhibit MMP activity, and the filler degradation rate is about 8% slower than during the follicular phase (after menstruation ends).
During menopause, the sharp drop in estrogen leads to an annual collagen loss of 2-3% (compared to only 0.5-1% during reproductive age).
For men, due to stable testosterone levels, hormones have a smaller impact on metabolism, and the fluctuation in filler maintenance time typically does not exceed 1 month.
Affecting Factors
The maintenance time of fillers is influenced by multiple factors. An 18-month follow-up study on 150 subjects showed that 74% still had a noticeable effect 12 months after injection, but only 35% remained at the 18th month.
Metabolic Rate Sets the Foundation
In healthy individuals aged 25, the activity of fibroblasts’ MMPs is about 0.05 mg of filler decomposed per hour, completing this process quickly;
For individuals aged 50 and above, due to the decline in cell mitochondrial function, MMP activity drops to 0.03 mg per hour, noticeably slowing the decomposition rate.
This difference is more pronounced in dynamic areas: due to frequent facial expression movements (over 10,000 times of smiling and talking daily), the fibroblast renewal rate in the perioral area is 15% faster than in the relatively static temporal area, leading to faster filler degradation in the perioral area.
The activity in the 30-40 age group, due to cell aging, dropped to 0.04-0.05 mg per hour, and maintenance time extended to 15-16 months;
In the 40-50 age group, activity further decreased to 0.03-0.04 mg per hour, and the metabolic cycle extended to 16-18 months.
In women during perimenopause (45-55 years), although the overall metabolic rate slows down due to decreased cell activity caused by a sharp drop in estrogen, native collagen loss accelerates (2-3% annually).
|
|
|
|
|
|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Metabolic Differences
Periorbital skin is thinnest, only 0.3-0.5 millimeters, with minimal subcutaneous fat. The filler is closer to the capillary network after injection, and decomposition products can quickly enter the bloodstream for metabolism. Retention rate after 6 months is only 42%.
Forehead skin is thicker (1-2 millimeters) and the subcutaneous fat layer is denser, cushioning the diffusion of decomposition products. The retention rate during the same period reaches 68%.
The nasolabial fold connects to the nasolabial sulcus, with the deep-seated levator labii superioris muscle contracting frequently (over 5,000 times daily). If the injection is too shallow (dermal layer), the filler is prone to displacement by muscle tension. Retention rate after 12 months is 15% lower than in the supraperiosteal layer.
These differences require a targeted adjustment of dosage when filling different areas in the same person—the recommended single-point dose for the periorbital area is 0.05-0.1 mL, while the forehead can be increased to 0.2-0.25 mL.
Lifestyle Habits
Aerobic exercise of moderate intensity (such as brisk walking, swimming) 3 times a week can increase facial skin blood flow by 20%, accelerating metabolic waste excretion. Filler retention rate in the cheeks after 6 months increases from 60% to 78%.
Chronic lack of sleep (<6 hours per night) keeps cortisol levels chronically elevated. This stress hormone inhibits fibroblast function. MMP activity is inhibited by 25% in individuals with chronically elevated cortisol, shortening filler maintenance time by 1-2 months.
In terms of diet, daily added sugar intake exceeding 50 grams (about 12 sugar cubes) activates Advanced Glycation End products (AGEs). These substances adhere to filler molecules, making them more easily recognized as a “foreign body” by the immune system. Clearance speeds up, and maintenance time is about 2 months shorter than for those who control sugar intake (<25 grams/day).
Vitamin C supplementation (100 mg daily) promotes native collagen synthesis. After 3 continuous months, filler retention rate in the forehead is 15% higher than in those who do not supplement, which is equivalent to maintaining the effect for an extra 1 month.
Injection Details Modify Duration
The supraperiosteal layer is close to the bone, and the connective tissue is tightly “netted,” resisting compression from muscle movement. Retention rate after 12 months can reach 82%;
If injected into the dermal layer, it’s only a single cell layer away from the epidermis. Any facial movement (such as smiling, frowning) compresses and displaces the filler, resulting in a retention rate of only 65% during the same period.
The subcutaneous fat layer is in between, suitable for areas like the tear trough that require light support. It’s neither too superficial nor pulled by deep muscles, with a retention rate of 75%.
Layer selection must also avoid blood vessels. For example, there is a branch of the facial artery beneath the nasolabial fold. Under standardized procedures, the risk of accidental vascular penetration is less than 0.03%.
Injection Speed Controls Distribution
Injecting too quickly (exceeding 0.3 mL/second) causes the material to “jet out” and disperse widely, easily going beyond the intended area. Effective volume retention is only 60% after 6 months;
Injecting slowly (0.1-0.2 mL/second) allows the material to accurately stay in the set layer, resulting in more uniform distribution, with an effective volume retention rate of 78% during the same period.
Excessive speed can also tear surrounding collagen fibers, causing facial swelling—when pressure exceeds 200 kilopascals, the probability of facial swelling 24 hours post-procedure increases from 12% to 35%.
|
|
|
|
|
|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Don’t Overdo Single-Point Dosage
Skin’s blood supply and metabolic capacity are limited. A single point exceeding 0.3 mL compresses capillaries, restricting oxygen and nutrient supply. Fibroblast activity decreases due to “starvation,” accelerating filler decomposition.
For cheek injections, controlling the single-point dosage to 0.1-0.2 mL results in an average maintenance time of 14 months;
If a single point exceeds 0.3 mL, the maintenance time shortens to 10 months, and the swelling period extends from 3 days to 7 days, with the area feeling hard to the touch.
Dosages vary across areas. Periorbital skin is as thin as paper (0.3-0.5 millimeters), so the single-point dosage should only be 0.05-0.1 mL. More can cause bulging, resembling “eye bags from a change in tear trough definition;”
Forehead tissue is thicker, allowing up to 0.2-0.25 mL, which provides sufficient support without excessive compression.
Area Adaptation Modifies Technique
Periorbital skin is only 0.3-0.5 millimeters thick, with minimal subcutaneous fat. Injecting into the supraperiosteal layer can cause pain and is prone to nodule formation. The deep dermis or superficial subcutaneous layer is preferred, as it supports fine lines without hindering blinking. Improvement in periorbital lines remains at 75% after 12 months.
The frontalis muscle in the forehead contracts over 10,000 times daily. If injected into the subcutaneous layer, muscle compression displaces the filler. Injection into the supraperiosteal layer “fixes” the filler, with the form retention rate 22% higher than in the subcutaneous layer within 6 months, preventing “forehead bulging when raising eyebrows.”
Innate Conditions Set the Range
For example, the thinnest periorbital skin is only 0.3-0.5 millimeters (about the thickness of a hair strand), with virtually no subcutaneous fat. The filler is separated from the capillaries by only a membrane, and decomposed small molecules can directly enter the bloodstream for metabolism—periorbital filler retention rate is only 42% after 6 months.
Conversely, forehead skin is 1-2 millimeters thick, and the subcutaneous fat layer acts as a “cushion,” locally blocking the diffusion of decomposition products. The retention rate during the same period increases to 68%.
Thin-skinned areas are also prone to accelerated displacement due to minor movements like rubbing eyes and frowning, further cutting the maintenance time by 10%-15%.
Genetic Background Sets Metabolic Baseline
Individuals carrying the fast-metabolism gene secrete MMPs 15% faster than the slow-metabolism type, essentially having a built-in “accelerated decomposition machine.” The filler’s metabolic cycle is 2-3 months shorter in their bodies than in others.
Also, twin studies show that the MMP activity difference between identical twins is only 5% (almost identical genes), while the difference in fraternal twins can be up to 20% (different genes).
|
|
|
|
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Age Structure Sets Innate Rhythm
Younger people (20-30 years old) have ample native collagen, losing only 0.5%-1% annually. The surrounding collagen “supports” the filler after injection. Although metabolism is faster, the result looks fuller—70% improvement is still maintained after 14 months.
By 40-50 years old, collagen loss is 2%-3% annually, and skin support weakens. Even if the filler metabolizes slowly, the surrounding collagen “collapses,” making the effect appear diminished—improvement in lines is only 55% after 12 months.
Hormone Baseline Affects Perceived Retention
Women during reproductive age (20-45 years old) have high estrogen levels, which inhibit collagenase activity, with collagen loss only at 0.5% annually.
During menopause (45-55 years old), estrogen drops sharply by over 70%, collagenase activity spikes, and collagen loss is 2%-3% annually. The skin slackens quickly. Even though the filler remains, the surrounding skin has collapsed, making the “filler protrude” or “lines not filled”—while the effect maintenance time is longer, visual satisfaction decreases by 40%.
For men, stable testosterone levels mean hormones have a smaller impact on metabolism, and the fluctuation in “perceived retention” of the filler does not exceed 10%.